Immunosuppression in Donation After Circulatory Death Liver Transplantation: Can Induction Modify Graft Survival?
Kevin Ig‐Izevbekhai, David S. Goldberg, Seth J. Karp, David P. Foley, Peter L. Abt – 24 June 2020 – Recipients of donation after circulatory death (DCD) LTs historically have an increased risk of graft failure. Antibody induction (AI) with antithymocyte globulin (ATG) or anti‐interleukin 2 receptor (anti‐IL2R) immunotherapy may decrease the incidence of graft failure by mitigating ischemia/reperfusion injury.